Otsuka Holdings Co Ltd
TSE:4578

Watchlist Manager
Otsuka Holdings Co Ltd Logo
Otsuka Holdings Co Ltd
TSE:4578
Watchlist
Price: 9 161 JPY -1.84% Market Closed
Market Cap: 5T JPY

Relative Value

The Relative Value of one Otsuka Holdings Co Ltd stock under the Base Case scenario is 8 371.46 JPY. Compared to the current market price of 9 161 JPY, Otsuka Holdings Co Ltd is Overvalued by 9%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
8 371.46 JPY
Overvaluation 9%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
53
Median 3Y
1.6
Median 5Y
1.6
Industry
2.6
Forward
2
vs History
88
vs Industry
35
Median 3Y
16.8
Median 5Y
16.5
Industry
21.7
Forward
14
vs History
20
vs Industry
33
Median 3Y
12.3
Median 5Y
11.1
Industry
16.6
vs History
9
vs Industry
17
Median 3Y
31.1
Median 5Y
28.3
Industry
22.5
vs History
6
vs Industry
47
Median 3Y
1.4
Median 5Y
1.2
Industry
2.3
vs History
3
vs Industry
55
Median 3Y
1.5
Median 5Y
1.4
Industry
2.9
Forward
1.8
vs History
3
vs Industry
65
Median 3Y
2.1
Median 5Y
2.1
Industry
5.5
vs History
23
vs Industry
38
Median 3Y
7.3
Median 5Y
7.5
Industry
13.1
Forward
7.6
vs History
57
vs Industry
38
Median 3Y
10
Median 5Y
10.1
Industry
16.6
vs History
17
vs Industry
35
Median 3Y
10.7
Median 5Y
9.6
Industry
15.8
vs History
53
vs Industry
24
Median 3Y
18.3
Median 5Y
17.4
Industry
19.1
vs History
6
vs Industry
47
Median 3Y
1.1
Median 5Y
1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Otsuka Holdings Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Otsuka Holdings Co Ltd
TSE:4578
4.8T JPY 2 10.8 7.9 9.8
US
Eli Lilly and Co
NYSE:LLY
955.6B USD 16.1 51.9 34.9 37.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
485.9B USD 5.3 19.3 15.8 20.5
CH
Roche Holding AG
SIX:ROG
247.6B CHF 4 26.3 11.3 13.1
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.8 29.9 108.2 158.4
CH
Novartis AG
SIX:NOVN
205.5B CHF 4.6 17.7 11.3 14.6
US
Merck & Co Inc
NYSE:MRK
248B USD 3.9 13 9.3 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.2 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
148B USD 2.4 15.1 7.6 10.4
P/E Multiple
Earnings Growth PEG
JP
Otsuka Holdings Co Ltd
TSE:4578
Average P/E: 21.9
10.8
-3%
N/A
US
Eli Lilly and Co
NYSE:LLY
51.9
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.3
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.1
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Otsuka Holdings Co Ltd
TSE:4578
Average EV/EBITDA: 398.5
7.9
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
34.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.8
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.3
4%
2.8
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Otsuka Holdings Co Ltd
TSE:4578
Average EV/EBIT: 1 708.5
9.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.4
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.1
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
158.4
23%
6.9
CH
Novartis AG
SIX:NOVN
14.6
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3